InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+82.9%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Donley Matthew Maxwell, Vice-Président Exécutif. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 10 reports have been recorded. Breakdown: 2 buys · 1 sell. Total volume traded: €334k. History available since 11 May 2021. The latest transaction was disclosed on 27 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Donley Matthew Maxwell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
58,160 股0Common StockSEC:0001600620-26-000022:0
32,901 股@ US$14.4054.7% 占其流量Common StockSEC:0001636642-26-000002:0
54,166 股0Common StockSEC:0001600620-26-000004:0
82,781 股0Common StockSEC:0001600620-25-000018:0
40,665 股@ US$5.5149.6% 占其流量Common StockSEC:0001600620-24-000036:0
216,666 股0Common StockSEC:0001600620-24-000020:0
271,134 股Common StockSEC:0001628280-23-006532:0
10,000 股@ US$4.6610.8% 占其流量Common StockSEC:0001628280-22-030745:0
标准退出：2023年2月19日 (T+90)
8,500 股0Common StockSEC:0001628280-22-005129:0
9,900 股@ US$10.074611.2% 占其流量Common StockSEC:0001628280-21-010023:0
标准退出：2021年8月9日 (T+90)
10 条申报中的 10 条
About Donley Matthew Maxwell
Matthew Maxwell Donley is the Executive Vice President of International Operations at Aurinia Pharmaceuticals Inc. In this role, he oversees international operations and contributes to the company's strategy. His experience in the pharmaceutical sector allows him to provide valuable insights on innovation and research. He is committed to supporting growth initiatives.
